- Home
- CWT vs TARS Comparison
CWT vs TARS Comparison
Compare CWT & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CWT | TARS |
|---|---|---|
| Founded | 1926 | 2016 |
| Country | United States | United States |
| Employees | 1105 | N/A |
| Industry | Water Supply | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CWT | TARS |
|---|---|---|
| Price | $49.62 | $76.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $54.75 | ★ $103.44 |
| AVG Volume (30 Days) | 404.4K | ★ 857.6K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | ★ 48.21 |
| EPS | ★ 2.07 | N/A |
| Revenue | ★ $963,695,000.00 | $451,360,000.00 |
| Revenue This Year | $11.21 | $64.28 |
| Revenue Next Year | $4.33 | $26.15 |
| P/E Ratio | $24.15 | ★ N/A |
| Revenue Growth | 6.41 | ★ 146.71 |
| 52 Week Low | $41.29 | $53.89 |
| 52 Week High | $53.82 | $91.53 |
Technical Indicators
Market Signals| Indicator | CWT | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 59.11 | 58.05 |
| Support Level | $48.83 | $67.49 |
| Resistance Level | $50.96 | $76.79 |
| Average True Range (ATR) | 1.00 | 3.88 |
| MACD | 0.23 | 0.48 |
| Stochastic Oscillator | 62.06 | 88.33 |
Price Performance
Historical ComparisonAbout CWT California Water Service Group
California Water Service Group is a U.S. water and utilities holding company based in California. The company provides water utility and other related services in California, Washington, New Mexico, Hawaii and Texas through its wholly-owned subsidiaries. The bulk of the company's business consists of the production, purchase, storage, treatment, testing, distribution, and sale of water for domestic, industrial, public, and irrigation uses, and the provision of water for domestic and municipal fire protection services.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.